Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Lymphoma
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter’s transformation and R/R MCL
Nirav Shah
• 15 Feb 2023
3:02
Phase I study of rapcabtagene autoleucel in patients with R/R DLBCL
Nirav Shah
• 15 Feb 2023
2:17
The importance of managing hematologic toxicity associated with CAR-T therapy
Marion Subklewe
• 10 Feb 2023
5:36
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy
Veit Buecklein
• 9 Dec 2022
1:23
CARBON trial: investigating CTX110 allogeneic CRISPR-Cas9–engineered CAR-Ts in R/R LBCL
Constantine Tam
• 12 Dec 2022
3:58
Results from the first-in-human trial of huCART19-IL18 in patients with R/R NHL and CLL
Jakub Svoboda
• 11 Dec 2022
1:00
Trials evaluating the efficacy of CD20 CAR-T cell therapy in WM and CNS lymphoma
Mazyar Shadman
• 9 Dec 2022
1:58
LMY-920 in non-Hodgkin lymphoma
Jeff Liter
• 27 Jan 2022
5:09
Mechanisms of resistance to CAR T-cell therapies
John Rossi
• 26 Aug 2021
4:24
Chimeric engulfment receptor (CER) T-cell therapy
John Rossi
• 26 Jul 2021
2:17
Liquid vs solid tumor strategies in cell therapy
Kanya Rajangam
• 13 Oct 2021
1:05
NKX019 in B-cell malignancies
Kanya Rajangam
• 13 Oct 2021
4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine
• 28 May 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu
• 3 Jun 2021
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini
• 20 May 2021
1:33
Improving education in cell therapy
Emanuele Ostuni
• 12 Apr 2021
1
2
3
Next